Abbott beats estimates, reports a 2.2% rise in Q1 sales

Abbott Laboratories on April 17 reported a 2.2% rise of $10 billion in its 2024 first-quarter sales which includes the impact of the anticipated decline in COVID-19 testing-related sales as compared to the previous year.Are you looking for signals & alerts from pro-traders? Sign-up to Invezz Signals™ for FREE. Takes 2 mins.Organic sales grew for the underlying base business of 10.8%, which represents the fifth consecutive quarter of double-digit growth. According to the report in the first quarter of 2024, ...